Cargando…
Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003
Since hepatitis B virus (HBV) infection can have serious sequelae, especially if infection occurs during childhood, there is a continuing need to examine its epidemiology so as to inform control measures. We analyzed trends in disease incidence and patterns of hepatitis B virus (HBV) transmission in...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1252726/ https://www.ncbi.nlm.nih.gov/pubmed/16239952 |
_version_ | 1782125735665729536 |
---|---|
author | Wu, H. X. Andonov, A. Giulivi, A. Goedhuis, N. J. Baptiste, B. Furseth, J. Poliquin, D. Chan, J. IP Bolesnikov, G. Moffat, B. Paton, S. Wu, J. |
author_facet | Wu, H. X. Andonov, A. Giulivi, A. Goedhuis, N. J. Baptiste, B. Furseth, J. Poliquin, D. Chan, J. IP Bolesnikov, G. Moffat, B. Paton, S. Wu, J. |
author_sort | Wu, H. X. |
collection | PubMed |
description | Since hepatitis B virus (HBV) infection can have serious sequelae, especially if infection occurs during childhood, there is a continuing need to examine its epidemiology so as to inform control measures. We analyzed trends in disease incidence and patterns of hepatitis B virus (HBV) transmission in both Canadian-born and non-Canadian-born children from 1999 to 2003, through the Enhanced Hepatitis Strain Surveillance System. Amongst Canadian-born children, the incidence of newly identified HBV infection per 100,000 declined significantly during the study period from 1.4 in 1999, to 0.5 in 2003 (RR, 0.75 per year; 95% CI, 0.60-0.95). Amongst non-Canadian-born children, the incidence of HBV infection per 100,000 ranged from 9.4 to 16.3, during the study period (linear trend test, p=0.69). Poisson regression analysis revealed that non-Canadian-born children were more likely to have HBV infection (RR, 12.3; 95% CI, 7.6 to 19.8), than Canadian-born children. HBV infection was found to be more common among children emigrating from high endemic area, than among Canadian-born children. Current Canadian immunization policy should take into consideration the protection of all children against HBV infection, including those coming from countries where mass hepatitis B vaccination programs have still not been launched. |
format | Text |
id | pubmed-1252726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-12527262005-10-20 Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003 Wu, H. X. Andonov, A. Giulivi, A. Goedhuis, N. J. Baptiste, B. Furseth, J. Poliquin, D. Chan, J. IP Bolesnikov, G. Moffat, B. Paton, S. Wu, J. Int J Med Sci Research Paper Since hepatitis B virus (HBV) infection can have serious sequelae, especially if infection occurs during childhood, there is a continuing need to examine its epidemiology so as to inform control measures. We analyzed trends in disease incidence and patterns of hepatitis B virus (HBV) transmission in both Canadian-born and non-Canadian-born children from 1999 to 2003, through the Enhanced Hepatitis Strain Surveillance System. Amongst Canadian-born children, the incidence of newly identified HBV infection per 100,000 declined significantly during the study period from 1.4 in 1999, to 0.5 in 2003 (RR, 0.75 per year; 95% CI, 0.60-0.95). Amongst non-Canadian-born children, the incidence of HBV infection per 100,000 ranged from 9.4 to 16.3, during the study period (linear trend test, p=0.69). Poisson regression analysis revealed that non-Canadian-born children were more likely to have HBV infection (RR, 12.3; 95% CI, 7.6 to 19.8), than Canadian-born children. HBV infection was found to be more common among children emigrating from high endemic area, than among Canadian-born children. Current Canadian immunization policy should take into consideration the protection of all children against HBV infection, including those coming from countries where mass hepatitis B vaccination programs have still not been launched. Ivyspring International Publisher 2005-10-01 /pmc/articles/PMC1252726/ /pubmed/16239952 Text en © Ivyspring International Publisher. This is an open access article. Reproduction is permitted for personal and noncommerical use, provided that the article is in whole, unmodified, and properly cited. |
spellingShingle | Research Paper Wu, H. X. Andonov, A. Giulivi, A. Goedhuis, N. J. Baptiste, B. Furseth, J. Poliquin, D. Chan, J. IP Bolesnikov, G. Moffat, B. Paton, S. Wu, J. Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003 |
title | Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003 |
title_full | Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003 |
title_fullStr | Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003 |
title_full_unstemmed | Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003 |
title_short | Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003 |
title_sort | enhanced surveillance for childhood hepatitis b virus infection in canada, 1999-2003 |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1252726/ https://www.ncbi.nlm.nih.gov/pubmed/16239952 |
work_keys_str_mv | AT wuhx enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT andonova enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT giulivia enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT goedhuisnj enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT baptisteb enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT fursethj enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT poliquind enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT chanjip enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT bolesnikovg enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT moffatb enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT patons enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 AT wuj enhancedsurveillanceforchildhoodhepatitisbvirusinfectionincanada19992003 |